The
local palm oil industry has been hit by two major scandals in recent times,
which scandals pose a risk to the health of consumers, subsequently, bad for palm
oil patronage. The primary issue here is the health of consumers; palm oil dealers’
financial concerns are secondary, though legitimate. The Food and Drugs Authority
(FDA) confirmed the first allegation and proceeded to sanction the offending
operators. In the second issue however, a week after a group of university
students publicized their research report that a cross section of palm oil
operators add centipedes to the oil during production, for colour and taste,
the FDA has refuted the claim, alongside
strong protests from the industry. There clearly are credibility issues that
must not be ignored.
A
spokesperson for the FDA indicated that the allegation is being investigated,
yet she declared her partiality by rubbishing the finding. She could not
concede that anyone would include centipede in palm oil, for any reason. Yes,
the researchers’ allegation is serious and needs thorough investigation. I am
concerned that the FDA would refute an allegation it is still investigating. Apparently,
the report came from the Kwame Nkrumah University of Science and Technology (KNUST).
Research ethics require that only legitimate reports are shared with the
community. Doubtful reports can be contested; therefore, the traders are right
in challenging the university to refute or substantiate the claim. One would
expect the same objective stance from the FDA.
Fact
is that the FDA is not the most credible and reliable agency for food safety in
spite of its national mandate. A while ago, when a researcher alerted the
public to the health hazards of plastics, a spokesperson from the Agency refuted
the allegations, claiming that the harm is not as high as the researcher
claimed. Yet, the harmful effects of Biphemol are well reported by researchers
globally. Communities interested in human safety now manufacture biodegradable
plastics, some of which are imported into the country. The mandate of the FDA notwithstanding,
food products of questionable safety are constantly on Ghanaian market shelves.
The report that centipedes are added to palm oil is alarming but not
surprising.
Every consumer of Ghanaian palm oil is interested in this issue; if some producers
could add bad chemicals to palm oil for colour, what prevents others from adding
centipedes to the product for the same effect? Some traders and manufacturers
have completely written off ethics and morality from their business catalogues.
A cross-section of farmers in the country adds carbide to food products to expedite
the ripening process. Such products can make consumers sick or die. Consumers
are ill-informed about the potential health risks of such contaminated food
products. That such contaminated products are rejected by the international
market alerts the local consumer that food in the country is not safe. Ironically,
outsiders will not eat it, but it is ok to sell the contaminated products to
Ghanaians.
Much
as I sympathize with the palm oil manufacturers and retailers, I prioritize
food and human safety. It might just be that a cross section of traders is
indulging in business malpractice. It could also be true that an unscrupulous
competitor, local or international, desires to eliminate all competition and
pave the way for a new palm oil product. Businesses engage in such unethical
behavior. In the same manner, some researchers breach research ethics and
disseminate false information. All the horrible scenarios I have painted above are
highly possible in a country which is clearly averse to quality. Therefore, this
is not the time for threats; it is time for proper investigation.
All
the agencies involved have so much at stake: KNUST is a reputable research Institution
which ought to abide by research ethics. It is expected to conduct legitimate
research and report credible outcomes. Research from both staff and students
must be above reproach. KNUST risks jeopardizing its research reputation,
locally and internationally, if it allowed false reports to be published or if it
its agencies compromised research ethics in any way. The Institution must
spearhead the investigation and muster the intellectual integrity to confirm the
authenticity or falsehood of the report in question. Should the report be found
to be false, the researchers involved must be appropriately sanctioned by the Institution
and its collaborators.
The
FDA must strive for public confidence and live up to its mandate through impartial
investigation of the allegation. It should identify the researchers and work to
get the truth. If it proved beyond all doubt that the researchers lied, it must
allay the fears of consumers and together with the traders, sue the offenders
for defaming the traders, raising false alarm and discrediting a legitimate
market product. But if the investigators reported a business malpractice, the FBA
should offer a public apology and ban the offenders from trading in any food
product. The Association would also apologize to the public, but it ought to
bear in mind that it would do irreparable damage to its Association should the
accusation be true. If it should happen that a business competitor raised the
false alarm in a perverse attempt to impose a new product on consumers, the
said product should be banned from the Ghanaian market for good.
Thorough
investigation is the only route through which the allegation of contaminated palm
oil on the market could be completely resolved. The final consumer must be kept
informed of the resolution process. Nothing should be left unexplained. All contending
stakeholders must provide irrefutable evidence to legitimize their claim. For
the sake of the ordinary Ghanaian consumer who could suffer serious health
effects for using the product, I hope the truth and nothing but the truth be told. The onus of responsibility lies on KNUST,
FDA and the aggrieved Palm oil manufacturer and retailers.